Fragile sites are preferential targets for integrations of MLV vectors in gene therapy (Q44345959)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q41590861)
(Q15972056)
(P304) 1057-1059
(P433) 13
(P478) 13
(P577) Thursday, March 2, 2006
(P921) (Q213901)
(P1433) (Q15763095)
(P1476) "Fragile sites are preferential targets for integrations of MLV vectors in gene therapy" (language: en)
(P2093) Bester AC
Schwartz M
Schmidt M
Hacein-Bey-Abina S
Ben-Porat N
Von Kalle C
Fischer A
Kerem B
(P2860) (Q28143064)
(Q28210584)
(Q45881891)
(Q35085395)
(Q28268332)
(Q33963998)
(Q40974841)
(Q45855127)
(Q29618456)
(Q43429483)
(Q24798872)
(Q74306391)
other details
description scientific article

External Links